Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.

Bonifati C, Argenziano G, Lembo S, Richetta AG, Romanelli M, Satolli F, Corazza M, Atzori L, Lasagni C, Potenza C, Savoia P, Bardazzi F, Di Lernia VG, Galluzzo M, Megna M, Giofrè C, Zichichi L, Guarneri C, Pallotta S, Fargnoli MC, Loconsole F, Offidani A, Burlando M, Piaserico S, Peris K, Papini M, Carrera CG, Prignano F, Bongiorno MR, Dapavo P, Stingeni L, Donini M, Micali G, Rongioletti F, Stinco G, Saibene F, Gramiccia T, Costanzo A

Open source

DOI
10.1080/09546634.2025.2600241
Published
2026 Dec
Container
The Journal of dermatological treatment
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/09546634.2025.2600241,
  title = {Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.},
  author = {Bonifati C and Argenziano G and Lembo S and Richetta AG and Romanelli M and Satolli F and Corazza M and Atzori L and Lasagni C and Potenza C and Savoia P and Bardazzi F and Di Lernia VG and Galluzzo M and Megna M and Giofrè C and Zichichi L and Guarneri C and Pallotta S and Fargnoli MC and Loconsole F and Offidani A and Burlando M and Piaserico S and Peris K and Papini M and Carrera CG and Prignano F and Bongiorno MR and Dapavo P and Stingeni L and Donini M and Micali G and Rongioletti F and Stinco G and Saibene F and Gramiccia T and Costanzo A},
  year = {2026},
  journal = {The Journal of dermatological treatment},
  doi = {10.1080/09546634.2025.2600241},
  url = {https://doi.org/10.1080/09546634.2025.2600241}
}

RIS

TY  - JOUR
TI  - Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.
AU  - Bonifati C
AU  - Argenziano G
AU  - Lembo S
AU  - Richetta AG
AU  - Romanelli M
AU  - Satolli F
AU  - Corazza M
AU  - Atzori L
AU  - Lasagni C
AU  - Potenza C
AU  - Savoia P
AU  - Bardazzi F
AU  - Di Lernia VG
AU  - Galluzzo M
AU  - Megna M
AU  - Giofrè C
AU  - Zichichi L
AU  - Guarneri C
AU  - Pallotta S
AU  - Fargnoli MC
AU  - Loconsole F
AU  - Offidani A
AU  - Burlando M
AU  - Piaserico S
AU  - Peris K
AU  - Papini M
AU  - Carrera CG
AU  - Prignano F
AU  - Bongiorno MR
AU  - Dapavo P
AU  - Stingeni L
AU  - Donini M
AU  - Micali G
AU  - Rongioletti F
AU  - Stinco G
AU  - Saibene F
AU  - Gramiccia T
AU  - Costanzo A
PY  - 2026
JO  - The Journal of dermatological treatment
DO  - 10.1080/09546634.2025.2600241
UR  - https://doi.org/10.1080/09546634.2025.2600241
ER  - 

APA

C, B., G, A., S, L., AG, R., M, R., F, S., M, C., L, A., C, L., C, P., P, S., F, B., VG, D. L., M, G., M, M., C, G., L, Z., C, G., S, P., MC, F., F, L., A, O., M, B., S, P., K, P., M, P., CG, C., F, P., MR, B., P, D., L, S., M, D., G, M., F, R., G, S., F, S., T, G., & A, C. (2026). Real-world effectiveness and safety of guselkumab in adult patients with facial and/or genital psoriasis: a 52-week analysis from the Italian multicentric GULLIVER study.. The Journal of dermatological treatment. https://doi.org/10.1080/09546634.2025.2600241

Source records